Kwality Pharmaceuticals Approves Key Board Appointments at 43rd AGM
Kwality Pharmaceuticals Ltd 路 Change in Management 路 03 Sept 2026, 4:59 am
Kwality Pharmaceuticals Approves Key Board Appointments at 43rd AGM At its 43rd AGM on 31st Aug'26, Kwality Pharmaceuticals' shareholders approved two key board appointments. Mr. Swanith Kapoor was regularized as a Non-Executive Independent Director for a five-year term spanning 2nd Jun'26 to 1st Jun'31. Furthermore, Mr. Aditya Arora was reappointed as Whole Time Director for five years, effective 30th Sep'26 to 29th Sep'31. Mr. Arora continues to oversee production, quality control, and regulatory filings. Both directors are cleared by SEBI to hold office, securing leadership continuity for the firm's operational and governance frameworks.
Original exchange filing (PDF)
More announcements from Kwality Pharmaceuticals Ltd
- Transcript of Earnings Conference Call - Q2FY2027 路 16 Nov 2026
- Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Recording of Investor/ Analyst Earnings Call held on November 13, 2026 路 14 Nov 2026
- Intimation under Regulation 30 of the SEBI(LODR), 2015 -Recording of Investor/ Analyst Earnings Call held on September 13, 2026 路 14 Nov 2026
- Investor Presentation for the quarter and half year ended unaudited financial results for 30-09-2026 路 12 Nov 2026
- Appointment of new Statutory Auditors 路 12 Nov 2026
- Resignation of Statutory Auditor 路 12 Nov 2026
- Approval of Unaudited Financial Results for the quarter and half year ended 30-09-2026. 路 12 Nov 2026
- Approval of Unaudited Financial Results for the quarter and half year ended 30-09-2026 路 12 Nov 2026
